Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease

阿尔茨海默病中的钙失调和内嗅皮层神经元的脆弱性

基本信息

  • 批准号:
    10459711
  • 负责人:
  • 金额:
    $ 69.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The broad, long-term objective of this multi-PI grant application is to understand the role of calcium (Ca2+) dysregulation as the mechanistic driver for synaptic loss between the lateral entorhinal cortex (LEC) and hippocampus (HPC) in evolving Alzheimer’s disease (AD). While dysfunction of LEC-HPC circuit has been implicated in the early stages of AD, the cause of this early, selective vulnerability of LEC neurons and disruption of LEC-HPC connections remain unknown. In our studies we will test the hypothesis that dysregulation of neuronal Ca2+ signaling plays a key role in LEC-HPC circuit dysfunction in early AD. Specifically, in experiments with the APPKI mouse model of AD, we will investigate if normalization of the activity of the Ca2+-dependent phosphatase calcineurin (CaN) rescues defects in LEC–HPC communication in early AD. The peptidyl-prolyl isomerase Pin1 is one of the key targets of CaN in neurons. Elevations in CaN inhibit Pin1, directly leading to synaptic and neuronal loss. In experiments with APPKI mice, we will determine if restoration of Pin1 activity rescues defects in LEC–HPC communication in early AD. We will use a combination of molecular, biochemical, imaging, electrophysiological, behavioral and neuropathological techniques to address these specific aims. If successful, our studies will provide a mechanistic rationale for the use of CaN inhibitors to treat early AD, potentially correcting early dysfunction of the LEC-HPC circuit and slowing AD development.
摘要

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Gating Mutation in Ryanodine Receptor Type 2 Rescues Phenotypes of Alzheimer's Disease Mouse Models by Upregulating Neuronal Autophagy.
2 型 Ryanodine 受体的门控突变通过上调神经元自噬来拯救阿尔茨海默病小鼠模型的表型。
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.
Cytoskeleton Protein EB3 Contributes to Dendritic Spines Enlargement and Enhances Their Resilience to Toxic Effects of Beta-Amyloid.
"Dirty Dancing" of Calcium and Autophagy in Alzheimer's Disease.
  • DOI:
    10.3390/life13051187
  • 发表时间:
    2023-05-15
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Alzheimer's disease - Where do we go from here?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ilya B Bezprozvanny其他文献

Ilya B Bezprozvanny的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ilya B Bezprozvanny', 18)}}的其他基金

Sigma 1 receptor as therapeutic target for Alzheimers disease treatment
Sigma 1 受体作为阿尔茨海默病治疗靶点
  • 批准号:
    10901028
  • 财政年份:
    2023
  • 资助金额:
    $ 69.82万
  • 项目类别:
Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease
阿尔茨海默病中的钙失调和内嗅皮层神经元的脆弱性
  • 批准号:
    10733805
  • 财政年份:
    2023
  • 资助金额:
    $ 69.82万
  • 项目类别:
Calcium signaling and synaptic maintenance in Alzheimers disease
阿尔茨海默病中的钙信号传导和突触维持
  • 批准号:
    9285585
  • 财政年份:
    2017
  • 资助金额:
    $ 69.82万
  • 项目类别:
Development of SK channel modulators as therapeutic agents for ataxia
开发 SK 通道调节剂作为共济失调治疗剂
  • 批准号:
    10311149
  • 财政年份:
    2017
  • 资助金额:
    $ 69.82万
  • 项目类别:
ConProject-001
ConProject-001
  • 批准号:
    10316591
  • 财政年份:
    2017
  • 资助金额:
    $ 69.82万
  • 项目类别:
Presenilins and neuronal calcium dyshomeostasis
早老素和神经元钙稳态失调
  • 批准号:
    9271268
  • 财政年份:
    2013
  • 资助金额:
    $ 69.82万
  • 项目类别:
Presenilins and neuronal calcium dyshomeostasis
早老素和神经元钙稳态失调
  • 批准号:
    8720077
  • 财政年份:
    2013
  • 资助金额:
    $ 69.82万
  • 项目类别:
Presenilins and neuronal calcium dyshomeostasis
早老素和神经元钙稳态失调
  • 批准号:
    8632540
  • 财政年份:
    2013
  • 资助金额:
    $ 69.82万
  • 项目类别:
Calcium channels as novel therapeutic targets for Huntingtons Disease
钙通道作为亨廷顿病的新治疗靶点
  • 批准号:
    8704830
  • 财政年份:
    2012
  • 资助金额:
    $ 69.82万
  • 项目类别:
Calcium channels as novel therapeutic targets for Huntingtons Disease
钙通道作为亨廷顿病的新治疗靶点
  • 批准号:
    8263938
  • 财政年份:
    2012
  • 资助金额:
    $ 69.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了